Home › Funds › Michelson Medical Research Foundation, Inc. › OCSL
Michelson Medical Research Foundation, Inc. position in OCSL
OAKTREE SPECIALTY LENDING · Financials
Michelson Medical Research Foundation, Inc. reported holding 170,100 shares of OCSL (OAKTREE SPECIALTY LENDING) in its Q3 2026 13F filing — a position valued at US$2.0M, representing 1.80% of its reported portfolio and ranking #18 among its reported holdings. Michelson Medical Research Foundation, Inc. has disclosed OCSL holdings in 3 of the last 3 reported quarters, going back to Q1 2026.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How Michelson Medical Research Foundation, Inc.'s OCSL position evolved
Michelson Medical Research Foundation, Inc. first disclosed a stake in OCSL in Q1 2026 at 170,100 shares (US$1.9M). The position peaked in Q2 2026 at 170,100 shares, worth US$2.0M. Across 3 filings, Michelson Medical Research Foundation, Inc. held the position steady without any share-count change. The most recent filing (Q3 2026) shows 170,100 shares valued at US$2.0M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2026 | 170.10K | $1.92M | New |
| Q2 2026 | 170.10K | $2.03M | Hold |
| Q3 2026 | 170.10K | $2.02M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About OCSL and 13F data
OCSL (OAKTREE SPECIALTY LENDING) is a Financials company. 19 other funds we track also report a position in OCSL — the largest reported positions include OAKTREE CAPITAL MANAGEMENT LP (US$94.0M), PRIVATE MANAGEMENT GROUP INC (US$47.7M), BRUNI J V & CO /CO (US$29.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding OCSL
- OAKTREE CAPITAL MANAGEMENT LP 7.87M sh · $93.99M · Q2 2026
- PRIVATE MANAGEMENT GROUP INC 4.01M sh · $47.72M · Q3 2026
- BRUNI J V & CO /CO 2.46M sh · $29.33M · Q3 2026
- ARES MANAGEMENT LLC 2.20M sh · $26.32M · Q2 2026
- Claret Asset Management Corp 1.76M sh · $20.95M · Q3 2026
- Melia Wealth LLC 680.22K sh · $8.09M · Q3 2026
- Muzinich & Co., Inc. 485.95K sh · $5.78M · Q3 2026
- Palliser Capital (UK) Ltd 438.04K sh · $5.21M · Q3 2026
More on Michelson Medical Research Foundation, Inc.
FAQ
How long has Michelson Medical Research Foundation, Inc. held OCSL?
Michelson Medical Research Foundation, Inc. has disclosed OCSL holdings in 3 of the last 3 reported quarters, going back to Q1 2026.
What is Michelson Medical Research Foundation, Inc.'s current position in OCSL?
As of Q3 2026, Michelson Medical Research Foundation, Inc. holds 170.10K shares of OCSL (OAKTREE SPECIALTY LENDING), valued at $2.02M, representing 1.80% of its reported portfolio and ranking #18.
Has Michelson Medical Research Foundation, Inc. been buying or selling OCSL?
In the latest 13F filing (Q3 2026), Michelson Medical Research Foundation, Inc. held unchanged its position in OCSL. The position peaked in Q2 2026 at 170.10K shares.
Which other funds hold OCSL?
Other major institutional holders of OCSL include OAKTREE CAPITAL MANAGEMENT LP, PRIVATE MANAGEMENT GROUP INC, BRUNI J V & CO /CO, among 19 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.